等待开盘 08-28 09:30:00 美东时间
-0.260
-0.73%
今日重点评级关注:花旗:维持Apellis Pharmaceuticals"买入"评级,目标价从46美元升至52美元;BTIG:维持Strategy"买入"评级,目标价从620美元升至700美元
08-04 09:30
UBS analyst Joshua Spector maintains Methanex (NASDAQ:MEOH) with a Buy and lowers the price target from $51 to $48.
07-31 22:33
Methanex (NASDAQ:MEOH) reported quarterly earnings of $0.97 per share which beat the analyst consensus estimate of $0.29 by 236.81 percent. This is a 56.45 percent increase over earnings of $0.62 per share from the same
07-31 05:03
Methanex (NASDAQ:MEOH) declares $0.185/share quarterly dividend, in line with previous. Forward yield 2.17% Payable Sept. 30; for shareholders of record Sept. 16; ex-div Sept. 16. See MEOH Dividend Sc...
07-18 12:14
Methanex Corporation has declared a quarterly dividend of US$0.185 per share, payable on September 30, 2025, to shareholders of record on September 16, 2025. The company, headquartered in Vancouver, is the world's largest methanol supplier and its shares trade on the Toronto Stock Exchange and Nasdaq under the symbols "MX" and "MEOH," respectively. For more information, visit www.methanex.com.
07-17 23:47
今日重点评级关注:花旗:维持Ducommun"买入"评级,目标价从186美元升至190美元;摩根大通:维持Sunrun"超配"评级,目标价从13美元升至16美元
07-16 08:33
UBS analyst Joshua Spector maintains Methanex (NASDAQ:MEOH) with a Buy and raises the price target from $50 to $51.
07-09 22:52
Methanex Corporation has received all necessary regulatory approvals for its acquisition of OCI Global's international methanol business following the lapse of the U.S. Hart-Scott-Rodino Antitrust Act review period. The transaction is set to close on June 27, 2025, subject to customary conditions. Methanex CEO Rich Sumner expressed optimism about the strategic benefits of the acquisition and the swift integration of the new business. As the world...
06-12 12:00
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139478829918380033.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim:维持Metsera(MTSR)"买入"评级,目标价从56美元升至62美元</p> <p>• 摩根大通:维持Avidity Biosciences(RNA)"超配"评级,目标价从57美元升至59美元</
06-11 09:43
Top Wall Street analysts changed their outlook on these top names. For a comple...
06-10 21:20